108 related articles for article (PubMed ID: 2783154)
21. Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages.
Cantos G; Barbieri CL; Iacomini M; Gorin PA; Travassos LR
Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):155-60. PubMed ID: 8424752
[TBL] [Abstract][Full Text] [Related]
22. Leishmania donovani. Hamster macrophage interactions in vitro: cell entry, intracellular survival, and multiplication of amastigotes.
Chang KP; Dwyer DM
J Exp Med; 1978 Feb; 147(2):515-30. PubMed ID: 564391
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of antileishmanial drugs activities in an ex vivo model of leishmaniasis.
Terreros MJS; de Luna LAV; Giorgio S
Parasitol Int; 2019 Aug; 71():163-166. PubMed ID: 30991111
[TBL] [Abstract][Full Text] [Related]
24. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
Chu BC; Whiteley JM
J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
[TBL] [Abstract][Full Text] [Related]
25. Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo.
Sinha J; Mukhopadhyay S; Das N; Basu MK
Drug Deliv; 2000; 7(4):209-13. PubMed ID: 11195427
[TBL] [Abstract][Full Text] [Related]
26. Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro.
Chang KP; Dwyer DM
Science; 1976 Aug; 193(4254):678-80. PubMed ID: 948742
[TBL] [Abstract][Full Text] [Related]
27. The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulations.
Williams A; Goodfellow R; Topley N; Amos N; Williams B
Inflamm Res; 2000 Apr; 49(4):155-61. PubMed ID: 10858015
[TBL] [Abstract][Full Text] [Related]
28. Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes.
Murray HW
J Immunol; 1982 Jul; 129(1):351-7. PubMed ID: 6282967
[No Abstract] [Full Text] [Related]
29. The sensitivity of Leishmania species to aminosidine.
Neal RA; Allen S; McCoy N; Olliaro P; Croft SL
J Antimicrob Chemother; 1995 May; 35(5):577-84. PubMed ID: 7592170
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and biodistribution of methotrexate conjugated to mannosyl human serum albumin.
Sett R; Sarkar HS; Das PK
J Antimicrob Chemother; 1993 Jan; 31(1):151-9. PubMed ID: 8444658
[TBL] [Abstract][Full Text] [Related]
31. Effect of polyglutamylation of methotrexate on its accumulation and the development of resistance in the protozoan parasite Leishmania.
El-Fadili A; Richard D; Kündig C; Ouellette M
Biochem Pharmacol; 2003 Sep; 66(6):999-1008. PubMed ID: 12963486
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of in vitro macrophage digestion capacity by infection with Leishmania donovani (Protozoa: Kinetoplastida).
Kutish GF; Janovy J
J Parasitol; 1981 Aug; 67(4):457-62. PubMed ID: 7264834
[TBL] [Abstract][Full Text] [Related]
33. Failure of hamster macrophages to discriminate between infective and noninfective promastigotes of Leishmania donovani during attachment in vitro.
Giannini MS; D'Alesandro PA; Garcia CR; Saraiva EM
Infect Immun; 1981 Nov; 34(2):629-32. PubMed ID: 7309246
[TBL] [Abstract][Full Text] [Related]
34. Intracellular multiplication of Leishmania donovani during repeated passages in primary cultures of hamster peritoneal macrophages.
Chang KP
J Parasitol; 1978 Oct; 64(5):931-3. PubMed ID: 722464
[No Abstract] [Full Text] [Related]
35. Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways.
Reiner NE; Malemud CJ
J Immunol; 1985 Jan; 134(1):556-63. PubMed ID: 3917283
[TBL] [Abstract][Full Text] [Related]
36. Effect of bioamines on uptake of promastigotes of Leishmania donovani by hamster peritoneal macrophages.
Mitra S; Ghosh L; Chakrabarty P; Biswas M; Bhattacharyya FK; Ghosh DK
J Med Microbiol; 1992 Apr; 36(4):283-7. PubMed ID: 1313882
[TBL] [Abstract][Full Text] [Related]
37. Scavenger receptor-mediated delivery of muramyl dipeptide activates antitumor efficacy of macrophages by enhanced secretion of tumor-suppressive cytokines.
Srividya S; Roy RP; Basu SK; Mukhopadhyay A
J Leukoc Biol; 2000 May; 67(5):683-90. PubMed ID: 10811009
[TBL] [Abstract][Full Text] [Related]
38. Neoglycoprotein conjugated liposomes as macrophage specific drug carrier in the therapy of leishmaniasis.
Kole L; Sakar K; Mahato SB; Das PK
Biochem Biophys Res Commun; 1994 Apr; 200(1):351-8. PubMed ID: 8166705
[TBL] [Abstract][Full Text] [Related]
39. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
Hockmeyer WT; Walters D; Gore RW; Williams JS; Fortier AH; Nacy CA
J Immunol; 1984 Jun; 132(6):3120-5. PubMed ID: 6725948
[TBL] [Abstract][Full Text] [Related]
40. Destruction of Leishmania mexicana amazonensis amastigotes within macrophages in culture by phenazine methosulfate and other electron carriers.
Rabinovitch M; Dedet JP; Ryter A; Robineaux R; Topper G; Brunet E
J Exp Med; 1982 Feb; 155(2):415-31. PubMed ID: 7057140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
